Univariate analysis for response after infliximab: distribution of responses according to demographic and clinical characteristics
Characteristic . | No. . | No. CR/PR . | % . | P . |
|---|---|---|---|---|
| Age | .5 | |||
| 47 y and younger | 10 | 6 | 60 | |
| Older than 47 y | 11 | 8 | 73 | |
| Sex | .5 | |||
| Male | 14 | 10 | 71 | |
| Female | 7 | 4 | 57 | |
| Acute GVHD grade | .4 | |||
| 2 | 14 | 10 | 71 | |
| 3-4 | 4 | 2 | 50 | |
| Donor type | .2 | |||
| HLA-matched sibling | 11 | 6 | 55 | |
| MM rel/MUD | 10 | 8 | 80 |
Characteristic . | No. . | No. CR/PR . | % . | P . |
|---|---|---|---|---|
| Age | .5 | |||
| 47 y and younger | 10 | 6 | 60 | |
| Older than 47 y | 11 | 8 | 73 | |
| Sex | .5 | |||
| Male | 14 | 10 | 71 | |
| Female | 7 | 4 | 57 | |
| Acute GVHD grade | .4 | |||
| 2 | 14 | 10 | 71 | |
| 3-4 | 4 | 2 | 50 | |
| Donor type | .2 | |||
| HLA-matched sibling | 11 | 6 | 55 | |
| MM rel/MUD | 10 | 8 | 80 |
MM rel/MUD indicates mismatched related/matched-unrelated donor.